SFPQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.895000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.811600E-01
Normal-vs-Stage2
2.958400E-01
Normal-vs-Stage3
5.759700E-02
Normal-vs-Stage4
4.435600E-01
Stage1-vs-Stage2
8.068200E-01
Stage1-vs-Stage3
1.132280E-02
Stage1-vs-Stage4
3.025800E-02
Stage2-vs-Stage3
2.677600E-02
Stage2-vs-Stage4
1.266470E-02
Stage3-vs-Stage4
5.702500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.010200E-01
Normal-vs-AfricanAmerican
8.714000E-01
Normal-vs-Asian
1.038610E-01
Caucasian-vs-AfricanAmerican
2.898600E-01
Caucasian-vs-Asian
7.612200E-02
AfricanAmerican-vs-Asian
9.758300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.998800E-01
Normal-vs-Female
2.918600E-01
Male-vs-Female
7.632800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.515400E-01
Normal-vs-Age(41-60Yrs)
4.601000E-01
Normal-vs-Age(61-80Yrs)
2.600400E-01
Normal-vs-Age(81-100Yrs)
1.464450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.676400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.221800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.203200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.636100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.586100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.240800E-01
Normal-vs-Daily Drinker
3.095000E-01
Normal-vs-Weekly Drinker
3.667600E-01
Normal-vs-Occasional Drinker
2.445400E-01
Normal-vs-Social Drinker
3.488600E-01
Non Drinker-vs-Daily Drinker
6.037000E-01
Non Drinker-vs-Weekly Drinker
7.983200E-01
Non Drinker-vs-Occasional Drinker
2.863200E-01
Non Drinker-vs-Social Drinker
2.938600E-01
Daily Drinker-vs-Weekly Drinker
8.720400E-01
Daily Drinker-vs-Occasional Drinker
6.758600E-01
Daily Drinker-vs-Social Drinker
5.728600E-01
Weekly Drinker-vs-Occasional Drinker
6.284600E-01
Weekly Drinker-vs-Social Drinker
5.317400E-01
Occasional Drinker-vs-Social Drinker
8.143600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.364200E-01
Normal-vs-Grade 2
8.036200E-01
Normal-vs-Grade 3
8.077600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.616800E-01
Grade 1-vs-Grade 3
5.125400E-01
Grade 1-vs-Grade 4
6.364200E-01
Grade 2-vs-Grade 3
9.231800E-01
Grade 2-vs-Grade 4
8.036200E-01
Grade 3-vs-Grade 4
8.077600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.234400E-01
Normal-vs-NonDiabetic
1.652970E-01
Diabetic-vs-NonDiabetic
7.768800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.844600E-01
Normal-vs-NoPancreatitis
2.156600E-01
Pancreatitis-vs-NoPancreatitis
6.168600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.564000E-01
Normal-vs-N1
3.044200E-01
N0-vs-N1
7.186600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.205800E-01
Normal-vs-TP53-NonMutant
3.297400E-01
TP53-Mutant-vs-TP53-NonMutant
8.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
